Rheumatology (Oxford, England)
Comment on: risk of urinary tract infections associated with SGLT2 inhibitor use in patients with rheumatoid arthritis: a target trial emulation study: reply.
Naofumi Dobashi, Ken-Ei Sada, Masataka Kudo, Shigemi Morishita, Sho Sasaki, Narufumi Suganuma
Published: 202510.1093/rheumatology/keaf666
No abstract available for this study.